Clinical Sciences/Health Conditions
Lynn Gerber, MD (she/her/hers)
Dr.
Inova Health System and George Mason University
Bethesda, Maryland, United States
Siddhartha Sikdar, PhD
Professor
George Mason University
Fairfax, Virginia, United States
Yu-lin Hsu, PhD
Phd candidate
George Mason University
FAIRFAX, Virginia, United States
John Z. Srbely, PhD
Associate Professor
University of Guelph
Guelph, Ontario, Canada
Jay Shah, MD
Staff Physiatrist
National Institutes of Health
Bethesda, Maryland, United States
Seiyon B. Lee, PhD
Assistant Professor
George Mason University
Fairfax, Virginia, United States
Antonio Stecco, MD PhD
Assistant Professor
NYU Langone Health
New York, New York, United States
William F. Rosenberger, PhD
Distinguished University Professor
George Mason University
Arlington, Virginia, United States
Secili DeStefano, DPT
Owner
Optimal Motion
Herndon, Virginia, United States
Isaac P. Amouzou, MS Statistics
MS Student
George Mason University
Fairfax, Virginia, United States
Yonathan M. Assefa, BS
Special Volunteer
Rehabilitation Medicine Department, Clinical Center, National Institutes of Health
Alexandria, Virginia, United States
Samuel A. Acuña, PhD
Research Assistant Professor
George Mason University
Fairfax, Virginia, United States
Matin Jahani, PhD
PhD student
George Mason University
Fairfax, Virginia, United States
Chronic myofascial pain (cMP) is a common musculoskeletal disorder lacking universal diagnostic criteria. Assessment relies on palpation to identify myofascial trigger points (MTrPs) that are active (i.e., spontaneously painful) or latent (i.e., painful only upon compression), but often overlooks contributors to pain phenotypes commonly observed. We aimed to determine evaluations that better distinguish cMP phenotype.
We analyzed baseline data from a prospective observational study of people with neck/shoulder pain and pain-free individuals classified as active (spontaneously painful, n=34); latent (pain upon palpation, n=40); and pain-free (n=22). Assessments included: pain history, upper trapezius examination, patient-reported questionnaires: Pain intensity and interference (PEG); pain catastrophizing (PCS); PROMIS physical function (PF); sleep disturbance; anxiety (GAD-2); depression (PHQ-2); hypermobility (Beighton/Brighton); Objective measures: pressure pain threshold (PPT), quantitative sensory testing (QST). Group differences were evaluated using two-sample t-tests for continuous variables and Fisher’s exact test for proportions (significance level: α=0.05).
Physical examination and objective measures of pain/function differed across groups (p≤0.02). Pain history showed noteworthy differences (p< 0.01) between the active and latent/pain-free groups, while latent and pain-free groups were largely similar. Questionnaires captured important variation: PHQ, GAD-2, and PCS scores differed slightly between active and latent/pain-free groups, while PEG, PF, and sleep disturbance showed stronger separation (p< 0.01). GAD-2 differed between latent and pain-free groups (p=0.03), sleep disturbance did not reach significance (p=0.07). Presence of bilateral MTrPs was not different when comparing the active vs latent groups.
The standard clinical assessments distinguish individuals with spontaneous pain from other groups but don't distinguish latent from pain free. Psychosocial symptoms (anxiety, sleep disturbance) do distinguish latent from pain-free individuals. Presence of bilateral MTrPs does not distinguish those who are active form latent. Adding PROs contributes to characterization of cMP.